Handelsbanken Fonder
BNGO icon

Handelsbanken Fonder’s Bionano Genomics BNGO Stock Holding History

Handelsbanken Fonder’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-88
Closed -$136K – 1623
2022
Q1 		$136K Hold
88
– – ﹤0.01% 1672
2021
Q4 		$158K Buy
88
+37
+73% +$99K ﹤0.01% 1727
2021
Q3 		$167K Hold
51
– – ﹤0.01% 1662
2021
Q2 		$223K Buy
+51
New +$201K ﹤0.01% 1685

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder's BNGO Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Bionano Genomics (BNGO) in Q2 2022, closing a stake of 88 shares — an estimated $136K sold.

Handelsbanken Fonder first reported a position in BNGO in Q2 2021 and held it in 4 quarters. The position peaked at $223K in Q2 2021. 143 funds tracked by Wall St. Rank hold BNGO as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Bionano Genomics position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 88 Bionano Genomics shares in Q2 2022, an estimated $136K.
  • Handelsbanken Fonder first reported a position in Bionano Genomics in Q2 2021 and held it in 4 quarters.
  • Handelsbanken Fonder's Bionano Genomics position peaked at $223K in Q2 2021.
  • 143 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.